These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
939 related articles for article (PubMed ID: 17088138)
21. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation. Perros F; Hoogsteden HC; Coyle AJ; Lambrecht BN; Hammad H Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858 [TBL] [Abstract][Full Text] [Related]
22. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis. Han DM; Zhou B; Wang T; Wang XD; Fan EZ Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982 [TBL] [Abstract][Full Text] [Related]
23. The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice. Fuchiwaki T; Sun X; Fujimura K; Yamada H; Shibata K; Muta H; Podack ER; Kawauchi H; Yoshikai Y Eur J Immunol; 2011 Oct; 41(10):2947-54. PubMed ID: 21739429 [TBL] [Abstract][Full Text] [Related]
24. Clara cell 10-kDa protein inhibits T(H)17 responses through modulating dendritic cells in the setting of allergic rhinitis. Liu Y; Yu HJ; Wang N; Zhang YN; Huang SK; Cui YH; Liu Z J Allergy Clin Immunol; 2013 Feb; 131(2):387-94.e1-12. PubMed ID: 23273949 [TBL] [Abstract][Full Text] [Related]
25. Regulatory dendritic cells protect against allergic airway inflammation in a murine asthmatic model. Fujita S; Yamashita N; Ishii Y; Sato Y; Sato K; Eizumi K; Fukaya T; Nozawa R; Takamoto Y; Yamashita N; Taniguchi M; Sato K J Allergy Clin Immunol; 2008 Jan; 121(1):95-104.e7. PubMed ID: 17920666 [TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease. Ahrens B; Freund T; Rha RD; Dittrich AM; Quarcoo D; Hutloff A; Hamelmann E Exp Lung Res; 2009 May; 35(4):307-23. PubMed ID: 19415548 [TBL] [Abstract][Full Text] [Related]
27. Amelioration of experimental allergic rhinitis with suppression of topical immune responses by lack of IL-27/WSX-1 signaling. Shimanoe Y; Miyazaki Y; Hara H; Inokuchi A; Yoshida H Ann Allergy Asthma Immunol; 2009 Mar; 102(3):223-32. PubMed ID: 19354069 [TBL] [Abstract][Full Text] [Related]
29. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells. Mascarell L; Lombardi V; Louise A; Saint-Lu N; Chabre H; Moussu H; Betbeder D; Balazuc AM; Van Overtvelt L; Moingeon P J Allergy Clin Immunol; 2008 Sep; 122(3):603-9.e5. PubMed ID: 18774396 [TBL] [Abstract][Full Text] [Related]
30. Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model. Quan SH; Zhang YL; Han DH; Iwakura Y; Rhee CS Ann Allergy Asthma Immunol; 2012 May; 108(5):342-50. PubMed ID: 22541406 [TBL] [Abstract][Full Text] [Related]
31. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. Lambrecht BN; De Veerman M; Coyle AJ; Gutierrez-Ramos JC; Thielemans K; Pauwels RA J Clin Invest; 2000 Aug; 106(4):551-9. PubMed ID: 10953030 [TBL] [Abstract][Full Text] [Related]
32. [T-bet gene modified dendritic cells abrogate and reverse the airway inflammation in allergic asthma: experiment with mice]. Liu GL; Shi JH; Lin YG; Lu SD; Lin JT Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):519-23. PubMed ID: 19567069 [TBL] [Abstract][Full Text] [Related]
33. [Immunoregulatory role of 1, 25-dihydroxyvitamin D(3)-treated dendritic cells in allergic airway inflammation]. Xia JB; Wang CZ; Ma JX; An XJ Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):514-8. PubMed ID: 19567068 [TBL] [Abstract][Full Text] [Related]
34. Derp1-modified dendritic cells attenuate allergic inflammation by regulating the development of T helper type1(Th1)/Th2 cells and regulatory T cells in a murine model of allergic rhinitis. Yu S; Han B; Liu S; Wang H; Zhuang W; Huang Y; Zhang R Mol Immunol; 2017 Oct; 90():172-181. PubMed ID: 28802126 [TBL] [Abstract][Full Text] [Related]
35. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis. Won TB; Quan SH; Kim DY; Rhee CS; Lee CH Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603 [TBL] [Abstract][Full Text] [Related]
37. Lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis in BALB/c mice. Sasaki Y; Hayashi T; Hasegawa K Scand J Immunol; 2007 Dec; 66(6):628-35. PubMed ID: 17949409 [TBL] [Abstract][Full Text] [Related]
38. Antigen presenting cells in the nasal mucosa of patients with allergic rhinitis during allergen provocation. Godthelp T; Fokkens WJ; Kleinjan A; Holm AF; Mulder PG; Prens EP; Rijntes E Clin Exp Allergy; 1996 Jun; 26(6):677-88. PubMed ID: 8809425 [TBL] [Abstract][Full Text] [Related]
39. Phenotypic and molecular characteristics of nasal mucosal gamma delta T cells in allergic and infectious rhinitis. Pawankar RU; Okuda M; Suzuki K; Okumura K; Ra C Am J Respir Crit Care Med; 1996 May; 153(5):1655-65. PubMed ID: 8630617 [TBL] [Abstract][Full Text] [Related]
40. Expression of membrane-bound CD23 in nasal mucosal B cells from patients with perennial allergic rhinitis. Horiguchi S; Okamoto Y; Chazono H; Sakurai D; Kobayashi K Ann Allergy Asthma Immunol; 2005 Feb; 94(2):286-91. PubMed ID: 15765747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]